Home/Endolytix/Gary Paul Magnant

GP

Gary Paul Magnant

Co-Founder, Life Science Entrepreneur & Investor

Therapeutic Areas

Infectious Disease Antimicrobial Resistance

Endolytix Pipeline

Drug	Indication	Phase
ENTX_001	Nontuberculous Mycobacterial (NTM) Infections (MAC, M. abscessus)	Pre-clinical

Leadership Team at Endolytix

Jason Holder, PhD

Co-Founder, Biotech Researcher & Entrepreneur

Co-Founder, Diagnostics Entrepreneur & Investor

View full Endolytix profile